E-MTAB-2089 - Array CGH for treatment decision in metastatic breast cancer

Status
Last updated on 20 November 2013, released on 4 April 2014
Organism
Homo sapiens
Samples (125)
Array (1)
Protocols (5)
Description
Breast cancer includes a large number of genomic segments defined by targetable genomic alterations. This multicentre molecular screening program aims to identify these abnormalities in individual patients in order to propose a targeted therapy matched to the genomic alteration.
Experiment types
genotyping by array, disease state design, ex vivo, genotype design
Contact
Citation
Array CGH and DNA sequencing for treatment decision in metastatic breast cancer: A multicentre, prospective trial (SAFIR01/UNICANCER).
MIAME
PlatformsProtocolsFactorsProcessedRaw
Files
Investigation descriptionE-MTAB-2089.idf.txt
Sample and data relationshipE-MTAB-2089.sdrf.txt
Raw data (16)Click to browse raw data
Processed data (26)Click to browse processed data
Array designA-AFFY-142.adf.txt
Links